| Hans-Günter Meyer-Thompson | Verschiedene
New Compound Related to Psychedelic Ibogaine Could Treat Addiction, Depression
New Compound Related to Psychedelic Ibogaine Could Treat Addiction, Depression
A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers at the University of California, Davis. A paper describing the work is published Dec. 9 in Nature. (UCD - University of California Davis, USA, 09.12.2020)
https://www.ucdavis.edu/news/new-compound-related-psychedelic-ibogaine-could-treat-addiction-depression